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We present the results of a collaborative study for the establishment of a replacement International
Standard (IS) for diphtheria toxoid for use in ﬂocculation test and its calibration in Lf units. Calibration
was performed using Ramon ﬂocculation method, standardized using the 2nd IS. The candidate standard
was assigned a unitage of 1870 Lf/ampoule based on results from 25 laboratories in 15 different countries
and was established as the 3rd IS for diphtheria toxoid for use in ﬂocculation test by the WHO Expert
Committee on Biological Standardization (ECBS) in October 2015.
The study also assessed the use of alternative methods for measuring Lf. Participants were asked to
determine the Lf value of the candidate standard using an Enzyme Linked Immunosorbent Assay (ELISA)
established at NIBSC, or other suitable in-house method. 10 laboratories performed ELISA according to
the NIBSC protocol, 1 laboratory performed ﬂocculation using laser-light scattering according to an in-
house protocol, and 1 laboratory performed another in-house ELISA. Results suggest these methods
may provide suitable alternatives to the Ramon ﬂocculation test, subject to validation, and that the new
standard could act as a suitable reference preparation in these methods.
Crown Copyright © 2016 Published by Elsevier Ltd on behalf of International Alliance for Biological
Standardization. This is an open access article under the Open Government License (OGL) (http://
www.nationalarchives.gov.uk/doc/open-government-licence/version/3/).1. Introduction
Diphtheria is caused by exotoxin-producing strains of the bac-
terium Corynebacterium diphtheriae. Active immunization against
diphtheria is based on the use of diphtheria toxoid (DTxd), a
chemically detoxiﬁed preparation of diphtheria toxin, to induce
protective antibody responses. Diphtheria vaccines form an
essential component of the primary immunization schedule of
children and have been part of the WHO Expanded Programme on
Immunization (together with tetanus and pertussis components)
since its inception in 1974 [1]. The bulk toxoid intermediates of
diphtheria vaccines can also be used as carrier proteins in poly-
saccharide conjugate vaccines against invasive bacterial infectionsECBS, Expert Committee on
munosorbent Assay; DTxd,
t tube to ﬂocculate); Lf-eq, Lf
bes).
vier Ltd on behalf of International
ives.gov.uk/doc/open-government-caused by Neisseria meningitidis, Haemophilus inﬂuenzae and
Streptococcus pneumoniae [2].
DTxd is produced by growing a toxigenic strain of C. diphtheriae
in liquid media and converting the toxin to inactive toxoid by
treatment with formaldehyde [1]. Antigenic strength and purity of
the bulk toxoid is evaluated by measurement of ‘limit of ﬂoccula-
tion’ (Lf) units. DTxd for use in production of vaccines for human
use must meet minimum requirements for purity (Lf units per
milligram of protein nitrogen). The current WHO minimum
requirement for antigenic purity of DTxd has been set as not less
than 1500 Lf/mg of protein nitrogen [3]. Measurement of antigen
content in Lf also serves as a good indicator of the consistency of
production, and testing of the crude toxin prior to inactivation is
recommended for monitoring purposes [3].
Flocculation is an in vitro method based on the observation
that antigen and antibody aggregate and form visible ﬂoccules
when mixed in certain proportions in solution. The precipitate
develops more rapidly when equivalent amounts of antigen and
antitoxin are present than when an excess of either is available
[4]. In the original Ramon ﬂocculation method [5e7] the antigenAlliance for Biological Standardization. This is an open access article under the Open
licence/version/3/).
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are added to a series of tubes. The antitoxin content of the ﬁrst
tube to ﬂocculate can be used to calculate the Lf value of the
sample. The time in minutes for the ﬁrst tube to ﬂocculate is
known as the Kf value, and is a useful indicator of the quality of
the antigen and antitoxin used.
The ﬂocculation unit was originally a relative unit deﬁned as the
amount of toxin (or toxoid) equivalent to one IU of antitoxin in the
ﬂocculation test (Ramon version) [8]. In 1970 the WHO Expert
Committee on Biological Standardization decided to examine the
feasibility of deﬁning the Lf unit internationally by means of a
reference toxoid preparation calibrated in Lf, rather than by means
of an antitoxin preparation [9]. Subsequently the 1st International
Reference Reagent of Diphtheria Toxoid for Flocculation Test (DIFT)
was established in 1989, calibrated using the ﬁfth International
Reference Preparation of Diphtheria Antitoxin for the Flocculation
Test (DIF), carrying the valid Lf deﬁnition at the time [10,11]. DIFT
was replaced with the 2nd International Standard (IS) for Diph-
theria toxoid for use in Flocculation test (02/176) in 2007 following
depletion of stocks [12].
Due to its simplicity, speed and economy, ﬂocculation remains
the primary method used by vaccine manufacturers to evaluate
toxin and toxoid concentrations in Lf. Most laboratories use the
toxoid IS to calibrate a suitable antitoxin in Lf-equivalent (Lf-eq)
units. This antitoxin can then be used routinely to estimate Lf values
of unknown toxin or toxoid samples. Various modiﬁcations of the
original Ramon ﬂocculation test exist, for example, keeping anti-
toxin concentration constant and adding different amounts of an-
tigen (Dean-Webb method [13]), or varying the concentrations of
both components simultaneously (Levine-Wyman method [14]).
However different versions of the method give different equiva-
lence amounts, therefore it is important that the same version of
the test is used for calibration of the local reference antitoxin and
for routine use [11].
Stocks of the 2nd IS (02/176) are in limited supply and a project
was initiated to calibrate and establish a replacement standard.
Candidate material for the replacement standard was provided to
NIBSC for formulation and ﬁlling prior to freeze-drying. A similar
material from another manufacturer was also provided to NIBSC,
and prepared in the same way, for a proposed new Pharmaco-
poeial Reference Standard (RS) for Diphtheria Toxoid. Collabora-
tive study (NIBSC code CS509) was initiated with the primary aim
of calibrating these materials in Lf units using Ramon ﬂocculation
test standardized against the 2nd IS. 26 laboratories in 15 coun-
tries (Argentina, Belgium, Canada, China, Croatia, Cuba, Denmark,
France, Hungary, India, Indonesia, Japan, Republic of Korea, The
Netherlands and United Kingdom) participated in the collabora-
tive study and 25 of these performed ﬂocculation assays used forTable 1
Details of bulk material and ﬁlled products.
Details of bulk material Toxoid A
Lot number D-70-01
Antigenic purity 2141 Lf/mg PN
Lf content (manufacturer) 1840 Lf/ml
Lf content (NIBSC ELISA) 1942 Lf/ml
Details of ﬁlled product Preparation A
NIBSC code 13/212
No. Ampoules ﬁlled 5109
Appearance Robust homog
Mean ﬁll mass 1.01 g (CV 0.21
Mean dry weight 0.03 g (CV 0.62
Mean residual moisture 0.38% (CV 15.2
Mean oxygen head space 0.64% (CV 16.7
Lf content (NIBSC ELISA) 1847 Lf/ampou
Lf content (NIBSC ﬂocculation) 1840 Lf/ampoucalibration of the candidate standards. A secondary aim of the
collaborative study was to assess the suitability of alternative
antigen detection methods for measuring Lf of diphtheria toxoid.
10 laboratories performed a capture ELISA assay developed at
NIBSC. In addition 1 laboratory returned results from another in-
house ELISA and 1 laboratory performed an alternative ﬂoccula-
tion method using laser light scattering to obtain a more objective
detection of antigeneantibody complexes. The participating lab-
oratories are listed in the Appendix and are referred to throughout
this report by a code number, allocated at random, and not related
to the order of listing.
2. Materials and methods
2.1. Bulk material and processing
Puriﬁed diphtheria toxoids were provided by two different
manufacturers and were identiﬁed as Toxoid A (candidate
replacement IS) and Toxoid B (candidate RS). Both materials com-
plied with the required quality control tests for bulk puriﬁed tox-
oids including safety, sterility and antigenic purity (>1500 Lf/mg
PN). Full details of the two materials are summarized in Table 1.
Each batch of diphtheria toxoid was stabilized by the addition of
0.1 M sodium chloride and 1% trehalose before freeze-drying.
Filling (1 ml per ampoule) was performed within NIBSC's Stan-
dard Processing Division on 21st November 2013 (Toxoid A) and
15th May 2014 (Toxoid B) using an automated ﬁlling line (Bausch &
Stroebel, Ilshofen, Germany). The material was stirred constantly
during ﬁlling and the temperature was maintained between þ4
and 8 C. The ﬁlled ampoules were freeze-dried using a Serail
CS100 freeze-dryer (Le Coudray St Germer, France). The freeze-
drying programme was initiated on the day of ﬁlling and set as
follows: The product was frozen over 90 min to50 C and held for
4 h before applying vacuum. Primary drying was at 40 C shelf
temperature and 30 mbar vacuum for 40 h. This was followed by a
15 h ramp toþ30 C and a secondary drying at that temperature for
a further 20 h. Ampoules were back-ﬁlled with dry nitrogen to
atmospheric pressure, stoppered in-situ, followed by ﬂame sealing.
The ﬁnished products were coded 13/212 (Toxoid A) and 14/132
(Toxoid B) and were stored at 20 C in the dark at NIBSC. The
freeze-dried candidate standards 13/212 and 14/132 were labelled
as Preparation A and Preparation B respectively for the collabora-
tive study and are referred to as such hereafter.
2.2. Post ﬁll characterization of candidate standards
Freeze-dried candidate toxoids were examined for appearance,
residual moisture content, oxygen head space and total antigenToxoid B
292202 (diluted)
2197 Lf/mg PN
750 Lf/ml
743 Lf/ml
Preparation B
14/132
6810
enous cake Robust homogenous cake
%) (n ¼ 179) 1.01 g (CV 0.14%) (n ¼ 232)
%) (n ¼ 6) 0.03 g (CV 2.04%) (n ¼ 6)
7) (n ¼ 12) 0.58% (CV 21.70) (n ¼ 12)
2) (n ¼ 12) 0.30% (CV 36.06) (n ¼ 12)
le 686 Lf/ampoule
le 675 Lf/ampoule
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poules after ﬁll. Representative ampoules were weighed at 1 min
intervals throughout the production run. A total of 179 ampoules
were weighed for Preparation A and a total of 232 ampoules were
weighed for Preparation B. Measurement of the mean oxygen
head space after sealing served as a measure of ampoule integrity.
The mean oxygen head space was measured non-invasively by
frequency modulated spectroscopy (FMS 760, Lighthouse In-
struments, Charlottesville, USA). Residual moisture content was
measured using the coulometric Karl Fischer method in a dry box
environment (Mitsubishi CA100, A1 Envirosciences, Cramlington,
UK) with total moisture expressed as a percentage of themean dry
weight of the ampoule contents.
2.3. Ramon ﬂocculation test
The Lf content of the freeze dried toxoids was measured at
NIBSC using Ramon ﬂocculation assay [15,16]. Firstly, the Lf-eq
value of NIBSC antitoxin 63/007 was determined using the 2nd
IS (02/176, 1100 Lf/ampoule). A series of tubes were prepared
containing 50 Lf of the 2nd IS and varying amounts of antitoxin in
the range of 40e60 IU, in a total volume of 2 ml. The tubes were
placed in a water bath at þ50 C so that the lowest third of the
mixture was submerged and observed for signs of ﬂocculation.
The ﬁrst tube in which ﬂocculation appeared contained 50 Lf-eq
units of antitoxin. The volume of antitoxin added to this tube
was used to calculate the Lf-eq value of the original antitoxin
sample, taking any initial dilution factor into account. The time
taken for the ﬁrst tube to ﬂocculate (Kf value) was also recorded.
To measure the Lf content of the toxoid samples the ﬂocculation
test was repeated essentially as described above, but with the
tubes containing a deﬁned amount of antitoxin in the range of
35e65 Lf-eq units and toxoid to an assumed amount of 50 Lf. The
ﬁrst tube in which ﬂocculation appeared was used to calculate the
Lf value of the toxoid sample.
2.4. NIBSC capture ELISA
The Lf content of the liquid bulk materials and freeze-dried
toxoids was conﬁrmed using a capture ELISA developed at NIBSC
[17]. The assay is in routine use as a consistency assay for moni-
toring antigen content and degree of adsorption, and also serves as
the identity test for diphtheria antigen. The method was performed
as described previously [17], with the exception of using recently
prepared freeze-dried stocks of the capture and detection anti-
bodies (reconstituted in 0.5 ml H2O and diluted 1/200 for use in the
assay). The reference toxoid (02/176) and the candidate diphtheria
toxoid standards were titrated in the range of approximately
0.055e0.0004 Lf/ml for the assay.
2.5. Collaborative study design
An International collaborative study was organised by NIBSC for
calibration of the candidate standards in Lf units. The study was
also used to assess the suitability of alternative antigen detection
methods for measuring Lf of diphtheria toxoid. Ampoules of Prep-
aration A and Preparation B were sent to participants with in-
structions for storage and use, together with recommendations for
suitable initial dilutions based on preliminary antigen estimates
obtained at NIBSC.
2.5.1. Ramon ﬂocculation test for calibration of candidate standards
Ramon Flocculation method was deﬁned as the primary assay
for calibration, since the original deﬁnition of the Lf unit was the
amount of toxin or toxoid equivalent in the Ramon version of theﬂocculation test with one unit of antitoxin. Participants were
provided with method guidelines based on published methods
[15,16]. A total of 25 laboratories from 15 different countries
performed ﬂocculation assay for calibration of the toxoid stan-
dards. To ensure traceability of the Lf and to standardize ﬂoc-
culation results, all participants performed a preliminary
ﬂocculation assay to pre-calibrate their antitoxin preparation in
Lf-eq units using the 2nd IS. A summary of antitoxins used in the
study is given in Table 2. For calibration of the toxoid standards,
all participants performed four independent ﬂocculation tests
(using a new ampoule for every test) as requested, with the
exception of laboratory 3 where three assays were performed.
The assays were performed with increments of antitoxin ranging
from 2 Lf-eq to 10 Lf-eq between tubes. Several laboratories
(laboratory codes 7, 12, 14, 16 and 18) performed two tests with
each reconstituted ampoule of the candidate diphtheria toxoid
standards; one ‘broad’ range according to the antitoxin dilution
range suggested in the method guidelines, followed by one
‘narrow’ range using smaller increases from tube to tube to
obtain a more precise estimate of Lf. Laboratory 9 performed a
‘broad’ range and a ‘narrow’ range test for the ﬁrst assay and then
‘narrow’ range tests for the following three independent assays.
Two replicate tests were performed by laboratory 24 with each
reconstituted ampoule. The four independent assays performed
by laboratory 23 used a pooled sample of the reconstituted
preparations A and B rather than a new ampoule for every test.
For each ﬂocculation test participants recorded the ﬁrst, second
and third mixtures to ﬂocculate as well as the time taken for the
ﬁrst ﬂocculation to appear.
2.5.2. Alternative methods for Lf determination
A total of 10 laboratories performed the NIBSC capture ELISA.
One laboratory performed ﬂocculation assay by laser light-
scattering and one performed their own in-house ELISA assay. Es-
timates of diphtheria toxoid in Lf were standardized using the 2nd
IS. Participants performed three independent assays for each
alternative method using the same ampoule for all replicate assays,
with the exception of laboratory 23who performed 4 replicate tests
for NIBSC capture ELISA.
2.5.2.1. NIBSC capture ELISA. NIBSC capture ELISAwas performed as
described above (section 2.4). Participants were provided with
method guidelines and the critical antibody reagents used for
capture and detection of the diphtheria toxoid (NIBSC 10/130 and
10/128 respectively).
2.5.2.2. Flocculation assay by laser light-scattering. Flocculation
assay by laser light-scattering [15,18] was performed using a
platelet aggregometer. The assay was performed with a series of
three or four tubes containing 6.25 Lf-eq units to 12.5 Lf-eq units of
diphtheria antitoxin, and diphtheria toxoid to the assumed amount
of 10 Lf, in a total volume of 400 ml. The time taken to acquire
particle counts of 50,000 was recorded.
2.5.2.3. Other in-house ELISA assay. Plates were coated with diph-
theria antitoxin (ST-ADS-36-07) diluted to 1 Lf-eq/ml and blocked
with PBS þ 0.5% BSA. Samples and reference toxoid (02/176) were
then titrated in the range of approximately 0.5e0.004 Lf/ml. Bound
toxoid was detected with a horse anti-diphtheria peroxidase con-
jugated antibody followed by substrate.
2.5.3. Reporting of data and statistical analysis
All rawdata togetherwith assay details were returned to NIBSC to
permit independent analysis. For Ramon ﬂocculation test the anti-
toxin content (Lf-eq) of the ﬁrst tube inwhich ﬂocculation appeared
Table 2
Summary of antitoxins used by participants for ﬂocculation test.
Supplier Batch No. of labs Lf-eq units/ml Average Kf time, min
2nd IS 02/176 A
13/212
B
14/132
Bilthoven Biologicals 515/3 1 200 15 12 27
Biological E Ltd DAT/02/2014 1 104 5 4 12
Central Drugs Laboratory 01/11-DATF 1 100 18 8 10
DATF/0114 1 100 4 4 8
Institut of Immunology 207 1 3330 10 8 16
209 1 3429 12 8 20
Institute Finlay ADRF (10)/10 1 1400 5 5 8
NIFDC 0048 1 1000 13 11 25
NIID Lot 4 6 1109d (1100e1280) 7 (3e9) 7 (3e9) 12 (4e15)
NIBSC 63/007 5 619e (542e742) 56 (51e59) 74 (63e83) 167 (145e191)
PT. Bio Farma ST-ADS-36-07 2 2055 (1909e2200) 11 (8e14) 14 (10e19) 25 (16e35)
Sanoﬁ Pasteur S3181 1 1200 18 8 21
Serum Institute of India ADS 1/2008 1 1200 5 4 8
Statens Serum Institut 280571
Lot: 10829-03-0001
1 120a 53a 41b 81b
280571
Lot: 10829-03-0002
1 113a 51a 39c 76c
ViNS Bioproducts LTD 04AD13001 1 1000 7 8 9
Where more than one participant used the same antitoxin the average result taken across labs is shown with the range of lab means indicated in brackets.
Individual Lf-eq units and Kf times with 02/176 are from 1 assay with one exception.
Individual Kf times for candidate diphtheria toxoids 13/212 and 14/132 are the mean of 4 assays with two exceptions.
a Mean of 4 assays.
b 1 assay.
c Mean of 3 assays.
d When reconstituted in 1 ml.
e When reconstituted in 2 ml.
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from theNIBSC ELISAwere calculated relative to IS 02/176 byparallel-
line analysis using CombiStats [19]. A log transformationwas applied
to the assay responses and dilutions on a linear section used for
analysis. Linearityandparallelismwasassessedbyanalysisof variance
with deviations from linearity and parallelism considered signiﬁcant
at the 1% level (p < 0.01). For ﬂocculation by laser light scattering the
data was analysed using quadratic regression (log antitoxin concen-
tration vs. log time). Lf values were calculated as the local minimum
value of the regression curve. For the other in-house ELISA method,
datawas analysedusing a 4-parameterﬁt standard curve (logdose vs.
response), with concentrations (Lf/ampoule) of Preparations A and B
calculated from interpolated values.
Results from all valid assays were combined as unweighted
geometric means (GM) for each laboratory. For Ramon ﬂocculation
test and NIBSC ELISA these laboratory means were used to calculate
overall unweighted geometric means. Variability between assays
and laboratories was expressed using geometric coefﬁcients of
variation (GCV ¼ {10s1}  100% where s is the standard deviation
of the log10 transformed estimates). Comparisons between ﬂoccu-
lation and NIBSC ELISA assays were made by unpaired t-test of log
transformed results.3. Stability studies
To determine the stability of the candidate toxoids a thermally
accelerated degradation study and real time stability monitoring
programme was initiated at NIBSC. For the thermally accelerated
degradation study, representative samples (ampoules) for Prepa-
ration A and B were stored at þ4, þ20, þ37, þ45 and þ56 C in
addition to the recommended storage temperature of 20 C.
Samples (one ampoule from each temperature group) were
removed after storage for 1 month and 6 months and tested for Lf
content in a single assay. The real time stability of the freeze dried
material was assessed by comparing Lf values obtained for am-
poules stored at 20 C over time. Stability of the reconstitutedmaterial was also assessed by comparing Lf values obtained for
ampoules reconstituted and stored atþ4 C for up to 3monthswith
values for ampoules reconstituted on the day of the assay. Samples
were assessed using both Ramon ﬂocculation test (with NIBSC
antitoxin 63/007) and NIBSC capture ELISA assay.4. Results
4.1. Post ﬁll analysis of freeze-dried candidate standards
After ﬁlling and freeze-drying, the candidate replacement
WHO IS (Preparation A) and candidate Pharmacopoeial RS
(Preparation B) were examined for appearance, residual moisture
content, oxygen head space and antigen content. The lyophilized
product for both materials was of very good appearance, giving
rise to robust homogenous cakes. For Preparation A the mean ﬁll
mass was 1.01 g with a coefﬁcient of variation (CV) of 0.21%
(n ¼ 179), and for Preparation B the mean ﬁll mass was 1.01 g with
a CV of 0.14% (n ¼ 232). The mean oxygen head space was deter-
mined as 0.64% for Preparation A (n ¼ 12) and 0.30% for Prepa-
ration B (n ¼ 12). Residual moisture content was determined to be
0.38% for Preparation A (n ¼ 12) and 0.58% for Preparation B
(n ¼ 12). The details of the freeze-dried candidate toxoids are
summarised in Table 1. The candidate replacement IS fulﬁls the
WHO requirements [20] for reference preparations regarding
precision of ﬁll, residual moisture and oxygen head space. The
antigen content of the freeze dried standards was determined by
Ramon ﬂocculation and NIBSC capture ELISA against the 2ndWHO
IS. For Preparation A the antigen content was measured as 1847 Lf/
ampoule by ELISA and 1840 Lf/ampoule by ﬂocculation test. For
Preparation B the antigen content was measured as 686 Lf/
ampoule by ELISA and 675 Lf/ampoule by ﬂocculation test. Based
on antigen estimates obtained by ELISA for the bulk materials, the
recovery of antigen content after ﬁlling and freeze-drying was
estimated to be approximately 95% (Preparation A) and 92%
(Preparation B).
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Table 3 summarise the results (Lf/ampoule) obtained for
Preparation A and B in Ramon ﬂocculation assays. Where a labo-
ratory performed both ‘broad’ and ‘narrow’ antitoxin dilution
ranges, the results obtained using the ‘narrow’ range have been
used. Where replicate tests were performed the geometric mean
of the results was taken. One assay for each toxoid was excluded
from the results for laboratory 23 as the ﬁrst and second tubes to
ﬂocculate were more than one tube apart. The time taken for the
ﬁrst ﬂocculation to occur (Kf value) varied dramatically depending
on the antitoxin preparation used, and was noticeably long for
antitoxins 63/007 (NIBSC) and 280571 (SSI). A summary of
average Kf values observed for Preparations A and B for each
antitoxin is shown in Table 2.
4.2.1. Results for Preparation A
Analysis of results from all laboratories (n ¼ 25) gave an overall
geometric mean of 1874 Lf/ampoule (95% conﬁdence limits:
1839e1910; GCV 4.7%). Within-laboratory GCV's ranged from 0%
(all assays giving the same result) to 6%, with the exception of
laboratory 1. Using the ‘broad’ range results from laboratories 7, 12,
14, 16 and 18 gave a similar overall mean of 1870 Lf/ampoule (data
not shown). The average Kf ranged from 4 min to 74 min, and the
values were comparable to those obtained with the 2nd IS when
determining the Lf-eq of the antitoxin preparation (Table 2).
4.2.2. Results for Preparation B
An overall geometric mean of 714 Lf/ampoule (95% conﬁdence
limits: 691e738; GCV 8.2%; n¼ 25) was determined for Preparation
B. Within-laboratory GCV's ranged from 0% to 7%. Using the ‘broad’
range results from laboratories 7, 12, 14, 16 and 18 gave a similarTable 3
Flocculation assay results.
Lab Preparation A
Lf/ampoule GCV (%
Assay 1 Assay 2 Assay 3 Assay 4 GM
1 1944 1831 1627 2237 1897 14.2
2 1980 1980 1980 1980 1980 0
3 1800 1980 1944 e 1906 5.2
4 1980 1980 1980 1980 1980 0
5 1800 1800 1800 1800 1800 0
6 1980 1908 1908 1908 1926 1.9
7a 1800 1800 1800 1872 1818 2.0
8 1900 1900 1900 1900 1900 0
9 1908 1908 1908 1908 1908 0
10 1800 2000 1800 1960 1888 5.7
11 1800 1980 1800 1800 1843 4.9
12a 2016 2088 2016 2088 2052 2.0
13 1800 1800 1800 1800 1800 0
14a 1797 1797 1797 1797 1797 0
16a 1800 1872 1872 1800 1836 2.3
17 1800 1800 1800 1980 1843 4.9
18a 1800 1800 1872 1800 1818 2.0
19 1980 1908 1944 1980 1953 1.8
20 1800 1800 1980 1980 1888 5.7
21 1719 1891 1719 1719 1760 4.9
22 1980 1980 1980 1980 1980 0
23 1620 1710 . 1620 1649 3.2
24 1800 1980 1980 1888 1910 4.7
25 1980 1980 1800 1980 1933 4.9
27 1800 1800 1872 1872 1836 2.3
Overall GM (Lf/ampoule) 1874
95% conﬁdence intervals 1839e1910
GCV (%) 4.7
a Results from “narrow range” used.overall mean of 716 Lf/ampoule (data not shown). The average Kf
times ranged from 8 min to 167 min and in all cases were longer
than observed for Preparation A.4.3. Other assay methods
Table 4 summarise the results (Lf/ampoule) obtained for Prep-
arations A and B in NIBSC ELISA assays. No results were calculated
for laboratory 25 due to high residual error and poor model ﬁt. An
overall geometric mean of 1806 Lf/ampoule (95% conﬁdence limits:
1744e1870; GCV 4.6%; n¼ 9) was determined for Preparation A and
675 Lf/ampoule (95% conﬁdence limits: 647e705; GCV 5.8%; n ¼ 9)
for Preparation B. The result from laboratory 22 was found to be an
outlier for toxoid A (p < 0.05 in Grubbs' test on log laboratory
means) and results calculated excluding this lab were 1830 Lf/
ampoule (95% conﬁdence limits: 1791e1869; GCV 2.6%; n ¼ 8) for
Preparation A and 686 Lf/ampoule (95% conﬁdence limits:
667e706; GCV 3.5%; n ¼ 8) for Preparation B. Within-laboratory
GCV's ranged from 0.3% to 16.3%. No signiﬁcant difference be-
tween ﬂocculation and antigen results was detected for Preparation
A (p ¼ 0.209; lab 22 excluded) or Preparation B (p ¼ 0.170; lab 22
excluded).
For ﬂocculation assay by laser light scattering, geometric mean
values of 1903 Lf/ampoule and 721 Lf/ampoule were determined
for Preparation A and B respectively. The within-laboratory GCV
was 0.8% for Preparation A and 2.5% for Preparation B. For the other
in-house antigen ELISA, geometric mean values of 1920 Lf/ampoule
and 723 Lf/ampoule were determined for Preparation A and B
respectively. The within-laboratory GCV was 5.1% for Preparation A
and 5.6% for Preparation B.
Laboratory means for each toxoid and all assay types are shown
in Figs. 1 and 2.Preparation B
) Lf/ampoule GCV (%)
Assay 1 Assay 2 Assay 3 Assay 4 GM
720 720 678 763 720 4.9
645 645 645 645 645 0
e 675 705 735 705 4.4
750 750 750 750 750 0
675 675 675 675 675 0
705 705 675 705 697 2.2
720 690 720 720 712 2.2
750 750 750 750 750 0
750 750 750 750 750 0
750 750 750 717 742 2.3
750 750 750 750 750 0
900 870 870 870 877 1.7
600 600 600 600 600 0
671 671 671 671 671 0
720 750 750 750 742 2.1
825 825 750 750 787 5.7
690 690 690 690 690 0
750 750 795 750 761 3.0
750 750 750 750 750 0
645 645 645 645 645 0
750 750 750 750 750 0
675 . 675 600 649 7.0
675 712 675 675 684 2.7
675 750 750 750 731 5.4
675 675 675 675 675 0
714
691e738
8.2
Table 4
NIBSC capture ELISA results.
Lab Preparation A Preparation B
Lf/ampoule GCV (%) Lf/ampoule GCV (%)
Assay 1 Assay 2 Assay 3 Assay 4 GM Assay 1 Assay 2 Assay 3 Assay 4 GM
16 1746 1840 1866 e 1817 3.6 641 639 643 e 641 0.3
18 1705 1969 1778 e 1814 7.7 800 667 663 e 707 11.3
19 1882 1776 1929 e 1862 4.3 836 626 668 e 705 16.3
20 1657 1894 1805 e 1783 7.0 660 748 658 e 688 7.6
21 2056 1924 1731 e 1899 9.1 796 683 654 e 708 10.9
22 1687 1652 1549 e 1628 4.5 636 607 552 e 597 7.4
23 1748 1698 1865 1854 1790 4.7 650 675 687 673 671 2.3
25 e e e e e e e e e e e e
26 1793 1817 2065 e 1888 8.1 658 655 773 e 693 9.9
27 1720 1927 1728 e 1789 6.6 711 691 630 e 676 6.6
Overall GM (Lf/ampoule) 1806 675
95% conﬁdence intervals 1744e1870 647e705
GCV (%) 4.6 5.8
Overall GM (Lf/ampoule, excl. lab 22) 1830 686
95% conﬁdence intervals 1791e1869 667e706
GCV (%) 2.6 3.5
Fig. 1. Results (Lf/ampoule) for Preparation A.
Fig. 2. Results (Lf/ampoule) for Preparation B.
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The candidate standards were assessed over time using
Ramon ﬂocculation assay and NIBSC capture ELISA in the three
stability studies: thermally accelerated degradation, real time of
the freeze-dried material (20 C) and real time once recon-
stituted (þ4 C).
Linear regression trend analysis was used to conﬁrm sta-
bility of the standards at the normal storage temperature
of 20 C. The Lf content of the ampoules (as determined by
ELISA and ﬂocculation test) showed no signiﬁcant (p < 0.05)
increasing or decreasing trends over the period of assessment
(22 months for Preparation A and 17 months for Preparation B).
Results (Lf/ampoule) for independent assays at each time point
are shown in Fig. 3 (Preparation A) and Fig. 4 (Preparation B).
Comparable results were also obtained in both ﬂocculation and
ELISA for ampoules reconstituted and stored at þ4 C for up to
3 months (not shown). For the thermally accelerated degrada-
tion study, a preliminary assay was performed at 1 month,
followed by a later assay after 6 months of storage. Results are
summarised in Table 5 (Preparation A) and Table 6 (Preparation
B). There were no trends observed in Lf content after 1 month
of storage at elevated temperatures for either Preparation A or
Preparation B. There was however a temperature dependant
increase in Kf values obtained in the ﬂocculation test for both
preparations, with samples stored at þ45 C and þ56 C taking
particularly longer to ﬂocculate compared to the baseline
sample (20 C). After 6 months storage, in addition to the
extended Kf times, ﬂocculation results for Preparation A
showed a loss in Lf content for samples stored at þ37 C and
above. The Lf values expressed relative to the baseline sample
were used to ﬁt an Arrhenius equation relating degradation rate
to absolute temperature [21] and this analysis gave a predicted
loss of 0.018% per year when stored at 20 C. For Preparation
B, a ﬂocculation result was obtained for the baseline sample at
the 6 month time point, but for the sample stored at þ56 C
there was no visible ﬂocculation even after 4 h. As it was not
practical to measure any loss in Lf content (due to the associ-
ated long ﬂocculation times), the ﬂocculation assay with NIBSC
antitoxin 63/007 was considered unsuitable for predicting sta-
bility of Preparation B. NIBSC antigen ELISA results on the 6
month samples did not show any signiﬁcant loss in Lf content
for Preparation A or Preparation B.
Fig. 3. Real time (20 C) stability monitoring for Preparation A. Data shows results for Ramon ﬂocculation test (a) and NIBSC ELISA (b) obtained in independent assays (n ¼ 1, 3 or 4
as shown). The geometric mean and 95% conﬁdence intervals are plotted where applicable.
Fig. 4. Real time (20 C) stability monitoring for Preparation B. Data shows results for Ramon ﬂocculation test (a) and NIBSC ELISA (b) obtained in independent assays (n ¼ 1, 3 or 4
as shown). The geometric mean and 95% conﬁdence intervals are plotted where applicable.
Table 5
Results of accelerated thermal degradation study for Preparation A.
Storage
temperature (C)
Flocculation NIBSC antigen ELISA
1 month 6 month 1 month 6 month
Lf/ampoule Kf (min) Lf/ampoule Kf (min) Lf/ampoule 95% cl Lf/ampoule 95% cl
20 1777 68 1800 65 1653 1560e1751 1794 1734e1856
þ4 1683 70 1800 65 1614 1523e1710 1782 1723e1844
þ20 1683 75 1800 67 1662 1659e1762 1881 1818e1946
þ37 1777 75 1764 78 1635 1543e1732 1800 1740e1896
þ45 1683 80 1728 79 1576 1487e1670 1806 1724e1891
þ56 1683 85 1656 93 1658 1565e1757 1752 1670e1838
Table 6
Results of accelerated thermal degradation study for Preparation B.
Storage
temperature (C)
Flocculation NIBSC antigen ELISA
1 month 6 month 1 month 6 month
Lf/ampoule Kf (min) Lf/ampoule Kf (min) Lf/ampoule 95% cl Lf/ampoule 95% cl
20 644 140 675 160 571 541e602 682 661e704
þ4 644 135 ND e 560 531e591 642 622e663
þ20 644 139 ND e 583 552e614 629 609e649
þ37 644 145 ND e 567 537e598 680 657e704
þ45 608 180 ND e 557 528e588 690 608e783
þ56 644 210 No resulta e 544 516e574 664 589e749
ND ¼ not done.
a No ﬂocculation after 4 h.
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Two candidate standards were included in the collaborative
study; a proposed replacement WHO IS (Preparation A, NIBSC code
13/212) and a proposed new Pharmacopoeial RS (Preparation B,
NIBSC code 14/132). Both toxoids were stabilized with 0.1 M so-
dium chloride and 1% trehalose prior to ﬁlling and freeze-drying,
which is the same formulation as used previously for the 2nd
WHO IS for tetanus toxoid for use in ﬂocculation test [22]. The bulk
diphtheria toxoid provided for Preparation B had been pre-diluted
by the manufacturer, hence the lower Lf value for this material.
Results of the in-house capture ELISA on the ﬁnished product show
the recovery of diphtheria antigen to be very high after freeze-
drying, with an estimated recovery of 95% for Preparation A and
92% for Preparation B.
Ampoules coded Preparation A and Preparation B were tested
and conﬁrmed to comply with the requirements for reference
standards regarding precision of ﬁll (<0.25%), residual moisture
content (<1%) and oxygen head space (<1%). Based on the results of
Ramon ﬂocculation assay returned from 25 laboratories, 13/212
was recommended as a suitable replacement WHO International
Standard for Diphtheria Toxoid for use in Flocculation Test with an
assigned unitage of 1870 Lf/ampoule (rounded from 1874 Lf/
ampoule). This material was adopted as the 3rd IS by the WHO
ECBS in October 2015 [23].
In the collaborative study, participants used their routine
antitoxin for ﬂocculation assays, as the study to establish the 2nd
WHO IS for diphtheria and tetanus toxoid for ﬂocculation test
showed calibration values obtained with in-house antitoxins
were not different from those obtained with a common provided
antitoxin [12,22]. The antitoxins were pre-calibrated in Lf-eq
units to standardize results and ensure traceability of the Lf.
There was very good agreement of values obtained between
laboratories for both preparations (GCV of 4.7% for Preparation A
and 8.2% for Preparation B). The inter-laboratory variability was
similar to the intra-laboratory variability, conﬁrming that the use
of different antitoxins had limited impact on the assay precision.
The antigenic quality of Preparation A appears to be comparable
to the 2nd WHO IS (02/176), with similar Kf values observed. As
the bulk toxoid was donated by the same manufacturer for both
the current and replacement IS they were expected to have
similar qualities. In all cases Kf values were longer for Prepara-
tion B than for Preparation A indicating a difference in the an-
tigenicity of this material.
In general, the candidate standards ﬂocculated in an acceptable
time of between 4 and 30 min with the various antitoxins used in
the study. However, ﬂocculation reactions performed with either
NIBSC antitoxin (code 63/007) or Statens Serum Institut antitoxin
(Batch 280571) were signiﬁcantly longer, and an average Kf of
nearly 3 h was reported for Preparation B with NIBSC antitoxin 63/
007. Although there is no optimal Kf, very quick ﬂocculation re-
actions of less than a few minutes may be hard to interpret, whilst
very slow reactions are time consuming and not practical to
perform.
Thermally accelerated degradation studies performed at NIBSC
were used to predict the long term stability of the standards. After 1
month storage at elevated temperatures there was no change in Lf
content as determined by ﬂocculation assay. A prolongation of the
ﬂocculation time (Kf) however was observed, which is often the
ﬁrst indication of a change in conformation or degradation of tox-
oids. After 6 months of storage there was a small but temperature
dependant decrease in Lf content for Preparation A in ﬂocculationtest, which allowed for a prediction of stability to be made. At the
same time point, the antigen content determined by ELISA was not
different for samples incubated at high temperatures. We have
previously shown that the monoclonal antibody capture ELISA is
capable of detecting temperature-induced changes in the antigen
content of (liquid formulation) diphtheria vaccines [17] but the
results obtained in this collaborative study for freeze-dried diph-
theria toxoid suggest that the ﬂocculation test may be more sen-
sitive to subtle changes in antigen structure/integrity. Real-time
stability studies are on-going but data collected from 20 C
samples stored for up to 22 months (Preparation A) or 17 months
(Preparation B) do not indicate any stability issues. Both candidates
when reconstituted in saline are stable for 3 months at þ4 C. For
future stability monitoring of Preparation B it is proposed to use
another antitoxin, with a more suitable Kf time, in place of NIBSC
63/007.
The Ramon ﬂocculation assay is applicable for use with pu-
riﬁed diphtheria toxoids of high concentrations. It can also be
used to conﬁrm Lf content in ﬁnal vaccine products; however
other immunochemical methods with increased sensitivity can
be more appropriate for this purpose [15]. The measurement of
antigen content and degree of adsorption to adjuvant in ﬁnal
vaccine products are good indicators of the consistency of pro-
duction [3], and ELISA methods with their high sensitivity are the
only suitable methods for measuring low amounts of non-
adsorbed toxoid in vaccine supernatants. In this collaborative
study, Lf results determined using the NIBSC ELISA method were
not signiﬁcantly different to those obtained in the ﬂocculation
assays and suggest that this method may be suitable as an
alternative to the ﬂocculation test for routine measurement of Lf
content of diphtheria toxoid samples, subject to validation.
Although ELISA does not provide the additional information on
Kf-time that is obtained from the ﬂocculation test it may be more
suitable for routine use in terms of throughput and could be
applied as a common method through all stages of vaccine pro-
duction. The results obtained in the study suggest that the NIBSC
ELISA is transferable and that the WHO IS for diphtheria toxoid
for ﬂocculation test may act as a suitable reference reagent in the
assay. The method could be used to assign Lf units to future
toxoid standards, however in order to fully characterise the
candidate material Ramon ﬂocculation assay should still be
included. Results obtained in the other in-house methods used
(laser light scattering and ELISA) also compared well with results
of ﬂocculation tests although no formal conclusion can be made
due to the low number of laboratories performing each of these
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